Trigilio Jeffrey (CIK 0001838671)

Latest company ownership

CGEM - Cullinan Therapeutics, Inc.

Role: CFO

Shares held

100,000

Last filed at

Feb 23, 2024

Confidence Score

50.0

2025Q4

Confidence Score History

2021Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Dec 21, 2023	Dec 22, 2023	Cullinan Therapeutics, Inc.	CFO	Sell	26.3	-1,920	-2.24%	✗	$16.3K
Dec 18, 2023	Dec 20, 2023	Cullinan Therapeutics, Inc.	CFO	Sell	45.0	-398	-0.46%	✗	$3.3K
Dec 12, 2023	Dec 13, 2023	Cullinan Therapeutics, Inc.	CFO	Sell	26.3	-1,926	-2.18%	✗	$15K
Jun 20, 2023	Jun 21, 2023	Cullinan Therapeutics, Inc.	CFO	Sell	45.0	-399	-0.46%	✗	$5.2K
Jun 12, 2023	Jun 14, 2023	Cullinan Therapeutics, Inc.	CFO	Sell	45.0	-319	-0.37%	✗	$4.2K
May 18, 2023	May 19, 2023	Cullinan Therapeutics, Inc.	CFO	Sell	45.0	-399	-0.46%	✗	$3.5K
May 12, 2023	May 16, 2023	Cullinan Therapeutics, Inc.	CFO	Sell	45.0	-347	-0.40%	✗	$3K
Apr 18, 2023	Apr 20, 2023	Cullinan Therapeutics, Inc.	CFO	Sell	45.0	-398	-0.45%	✗	$4.3K
Apr 12, 2023	Apr 14, 2023	Cullinan Therapeutics, Inc.	CFO	Sell	45.0	-318	-0.36%	✗	$3.3K
Mar 20, 2023	Mar 27, 2023	Cullinan Therapeutics, Inc.	CFO	Sell	45.0	-399	-0.45%	✗	$4.5K
Oct 15, 2021	Oct 18, 2021	Cullinan Therapeutics, Inc.	CFO	Sell	10.0	-8,000	-78.05%	✓	$200K
Sep 8, 2021	Sep 9, 2021	Cullinan Therapeutics, Inc.	CFO	Sell	7.5	-15,000	-86.96%	✓	$427.2K
Jan 12, 2021	Jan 14, 2021	Cullinan Therapeutics, Inc.	CFO	Buy	91.3	+2,250	100.00%	✗	$47.3K